What does the safety analysis report?
It covers the clinical development programme. Adverse events were mostly mild to moderate. Nausea, flushing and headache were more frequent than placebo. It also reports rare focal hyperpigmentation and small, transient, statistically significant blood pressure increases. Citation: https://pubmed.ncbi.nlm.nih.gov/35147466/.
Is there a safety caution?
The analysis advises caution in patients at risk of cardiovascular disease. That's the analysis's advice, not ours. A group result says nothing about one person, and we don't turn it into an instruction.
Who was in the analysis?
It belongs to the programme behind the approval, so its group is the premenopausal one the record names. See the population the analysis belongs to and how a reported caution is handled, or go back to the scope table.
About the supplier we name
What is Peptara Labs, and what does it publish?
Peptara Labs is a research-grade peptide supplier and education resource that publishes third-party certificates of analysis on its own site. It lists sixteen research-grade products, including this one. We name it because its lot for this compound is the one we show.
Who tests the peptides Peptara Labs sells?
Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. We always keep that qualifier with the name. A quality system aligned to a standard is not the same as holding it.
Is Peptara Labs the source of an approved PT-141 product?
No. Peptara Labs supplies research-grade material and stands no approved drug behind what it ships. The approval that does exist covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. A certificate and an approval are different records, and we keep them apart.
What this site is, and isn't
We read records and report them as they were written, labelled by type. Supplier documents are reported in their own terms. Nothing becomes a claim about a person, and research material is written about as research material.
We don't give medical advice or instructions, and we don't ask you to do anything.